1-(4-chlorophenyl)-N,N-dimethylimidazo[1,5-a]pyrazin-3-amine;1-(4-chlorophenyl)-3-(4-methoxycyclohexyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxan-4-yl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;3-(oxan-4-yl)-1-phenylpyrazolo[5,4-c]pyridine
C101H98Cl5N19O5 — CID 158924078
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(4-chlorophenyl)-N,N-dimethylimidazo[1,5-a]pyrazin-3-amine;1-(4-chlorophenyl)-3-(4-methoxycyclohexyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxan-4-yl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;3-(oxan-4-yl)-1-phenylpyrazolo[5,4-c]pyridine
1-(4-chlorophenyl)-N,N-dimethylimidazo[1,5-a]pyrazin-3-amine;1-(4-chlorophenyl)-3-(4-methoxycyclohexyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxan-4-yl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;3-(oxan-4-yl)-1-phenylpyrazolo[5,4-c]pyridine (PubChem CID 158924078) has the molecular formula C101H98Cl5N19O5 and a molecular weight of 1835.29 g/mol. Its IUPAC name is 1-(4-chlorophenyl)-N,N-dimethylimidazo[1,5-a]pyrazin-3-amine;1-(4-chlorophenyl)-3-(4-methoxycyclohexyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxan-4-yl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;3-(oxan-4-yl)-1-phenylpyrazolo[5,4-c]pyridine.
Molecular Properties
| Compound Name | 1-(4-chlorophenyl)-N,N-dimethylimidazo[1,5-a]pyrazin-3-amine;1-(4-chlorophenyl)-3-(4-methoxycyclohexyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxan-4-yl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;3-(oxan-4-yl)-1-phenylpyrazolo[5,4-c]pyridine |
|---|---|
| PubChem CID | 158924078 |
| Molecular Formula | C101H98Cl5N19O5 |
| Molecular Weight | 1835.29 g/mol |
| Exact Mass | 1831.64 |
| IUPAC Name | 1-(4-chlorophenyl)-N,N-dimethylimidazo[1,5-a]pyrazin-3-amine;1-(4-chlorophenyl)-3-(4-methoxycyclohexyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxan-4-yl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;3-(oxan-4-yl)-1-phenylpyrazolo[5,4-c]pyridine |
| SMILES | CN(C)c1nc(-c2ccc(Cl)cc2)c2cnccn12.COC1CCC(c2nc(-c3ccc(Cl)cc3)c3cnccn23)CC1.Clc1ccc(-c2nc(C3CCOC3)n3ccncc23)cc1.Clc1ccc(-c2nc(C3CCOCC3)n3ccncc23)cc1.Clc1ccc(-c2nc(CC3CCOCC3)n3ccncc23)cc1.c1ccc(-n2nc(C3CCOCC3)c3ccncc32)cc1 |
| InChI | InChI=1S/C19H20ClN3O.C18H18ClN3O.C17H16ClN3O.C17H17N3O.C16H14ClN3O.C14H13ClN4/c1-24-16-8-4-14(5-9-16)19-22-18(13-2-6-15(20)7-3-13)17-12-21-10-11-23(17)19;19-15-3-1-14(2-4-15)18-16-12-20-7-8-22(16)17(21-18)11-13-5-9-23-10-6-13;18-14-3-1-12(2-4-14)16-15-11-19-7-8-21(15)17(20-16)13-5-9-22-10-6-13;1-2-4-14(5-3-1)20-16-12-18-9-6-15(16)17(19-20)13-7-10-21-11-8-13;17-13-3-1-11(2-4-13)15-14-9-18-6-7-20(14)16(19-15)12-5-8-21-10-12;1-18(2)14-17-13(10-3-5-11(15)6-4-10)12-9-16-7-8-19(12)14/h2-3,6-7,10-12,14,16H,4-5,8-9H2,1H3;1-4,7-8,12-13H,5-6,9-11H2;1-4,7-8,11,13H,5-6,9-10H2;1-6,9,12-13H,7-8,10-11H2;1-4,6-7,9,12H,5,8,10H2;3-9H,1-2H3 |
| InChIKey | JIEZYDUDGWAYTC-UHFFFAOYSA-N |
| XLogP | 22.67 |
| TPSA | 231.05 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 130 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1835.29 |
| LogP ≤ 5 | 22.67 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 24 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158924078 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.